Impax Asset Management Group
DXCM icon

Impax Asset Management Group’s DexCom DXCM Stock Holding History

Impax Asset Management Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-186,578
Closed -$12.5M – 322
2024
Q3 		$12.5M Hold
186,578
– – 0.05% 145
2024
Q2 		$21.2M Hold
186,578
– – 0.09% 127
2024
Q1 		$25.9M Sell
186,578
-54,643
-23% -$6.87M 0.1% 125
2023
Q4 		$29.9M Sell
241,221
-117,135
-33% -$12M 0.12% 120
2023
Q3 		$33.4M Buy
358,356
+26,911
+8% +$3.03M 0.15% 113
2023
Q2 		$42.6M Sell
331,445
-19,420
-6% -$2.35M 0.17% 105
2023
Q1 		$40.8M Buy
350,865
+19,636
+6% +$2.2M 0.17% 111
2022
Q4 		$37.5M Buy
331,229
+50,706
+18% +$5.57M 0.17% 112
2022
Q3 		$22.6M Buy
+280,523
New +$23.8M 0.12% 115

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Impax Asset Management Group's DXCM Position: Q4 2024 in Review

Impax Asset Management Group sold out of DexCom (DXCM) in Q4 2024, closing a stake of 186,578 shares — an estimated $12.5M sold.

Impax Asset Management Group first reported a position in DXCM in Q3 2022 and held it in 9 quarters. The position peaked at $42.6M in Q2 2023. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Impax Asset Management Group reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Impax Asset Management Group sold 186,578 DexCom shares in Q4 2024, an estimated $12.5M.
  • Impax Asset Management Group first reported a position in DexCom in Q3 2022 and held it in 9 quarters.
  • Impax Asset Management Group's DexCom position peaked at $42.6M in Q2 2023.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Impax Asset Management Group's 13F filing for Q4 2024, filed 4 Feb 2025.